Log in to save to my catalogue

Prognostic tools and candidate drugs based on plasma proteomics of patients with severe COVID-19 com...

Prognostic tools and candidate drugs based on plasma proteomics of patients with severe COVID-19 com...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_cc8863a6b1e1471e9fd13c683dc57019

Prognostic tools and candidate drugs based on plasma proteomics of patients with severe COVID-19 complications

About this item

Full title

Prognostic tools and candidate drugs based on plasma proteomics of patients with severe COVID-19 complications

Publisher

London: Nature Publishing Group UK

Journal title

Nature communications, 2022-02, Vol.13 (1), p.946-946, Article 946

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

COVID-19 complications still present a huge burden on healthcare systems and warrant predictive risk models to triage patients and inform early intervention. Here, we profile 893 plasma proteins from 50 severe and 50 mild-moderate COVID-19 patients, and 50 healthy controls, and show that 375 proteins are differentially expressed in the plasma of se...

Alternative Titles

Full title

Prognostic tools and candidate drugs based on plasma proteomics of patients with severe COVID-19 complications

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_cc8863a6b1e1471e9fd13c683dc57019

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_cc8863a6b1e1471e9fd13c683dc57019

Other Identifiers

ISSN

2041-1723

E-ISSN

2041-1723

DOI

10.1038/s41467-022-28639-4

How to access this item